HNF1B and cholangiocarcinoma: In a retrospective cohort of patients, including 183 HCC and 69 intrahepatic CCA, the overexpression of HNF1B by immunohistochemistry was an independent prognostic factor for overall survival and disease-free survival of HCC patients but not ICCAs patients.